click below
click below
Normal Size Small Size show me how
Endocrine 1
| Generic Name | Brand Name | Pharmacological Category | Common Indications | Classification |
|---|---|---|---|---|
| Metformin (PO) | Fortamet, Glutametza | Biguanide | Type 2 DM, PCOS | |
| Sitagliptin (PO) | Januvia, Zituvio | Dipeptidyl peptidase (DPP-4) inhibitor | Type 2 DM | |
| Empagliflozin (PO) | Jardiance | Sodium-glucose cotransport inhibitor 2 (SGLT2) inhibitor | Type 2 DM, HF, CKD | |
| Dapagliflozin (PO) | Farxiga | Sodium-glucose cotransport inhibitor 2 (SGLT2 inhibitor) | Type 2 DM, HF, CKD | |
| Glimepiride (PO) | Amaryl | Sulfonylurea | Type 2 DM | |
| Glipizide (PO) | Glucotrol, Glucotrol XL | Sulfonylurea | Type 2 DM | |
| Pioglitazone (PO) | Actos | Thiazolidine (TZD) | Type 2 DM | |
| Dulaglutide (SQ) | Trulicity | Glucagon-like peptide-1 (GLP-1) receptor agonist | Type 2 DM | |
| Liraglutide (SQ) | Victoza, Saxenda | Glucagon-like peptide-1 (GLP-1) receptor agonist | Type 2 DM, chronic weight management | |
| Semaglutide (PO, SQ) | SQ: Ozempic, Wegovy PO: Rybelsus | Glucagon-like peptide-1 (GLP-1) receptor agonist | Type 2 DM, chronic weight management | |
| Tirzepatide (SQ) | Monjouro, Zepbound | Dual GLP-1 and glucose dependent insulinotropic polypeptide (G1P) | Type 2 DM, chronic weight management | |
| Insulin Glargine (SQ) | Lantus, Toujeo, Basaglar | Insulin, long acting | Type 1 DM, Type 2 DM | |
| Insulin NPH (SQ) | Humulin N, Novolin N | Insulin, intermediate acting | Type 1 DM, Type 2 DM | OTC |
| Insulin aspart (SQ) | Novolog | Insulin, rapid acting | Type 1 DM, Type 2 DM | |
| Insulin lispro (SQ) | Humalog | Insulin, rapid acting | Type 1 DM, Type 2 DM | |
| Insulin regular (SQ,IV) | Humulin R, Novolin R | Insulin, short-acting | Type 1 DM, Type 2 DM, DKA | SQ:OTC |